Entity Addresses, Address Type [Axis]
Business Contact [Member]
Related and Nonrelated Parties [Axis]
Related Party [Member]
Nonrelated Party [Member]
Class of Stock [Axis]
Series B Convertible Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Equity Components [Axis]
Preferred Stock [Member]
Preferred Class B [Member]
Preferred Class C [Member]
Common Stock [Member]
Warrant [Member]
Subscription Receivable [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Sale of Stock [Axis]
IPO [Member]
Resale Prospectus [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Underwriting Agreement [Member]
Legal Entity [Axis]
Boustead Securities L L C [Member]
Over-Allotment Option [Member]
Title and Position [Axis]
Underwriters [Member]
Securities Purchase Agreement [Member]
Series B Preferred Stock [Member]
Equity Purchase Agreement [Member]
Commitment Shares [Member]
Award Type [Axis]
Thrid Closing Date [Member]
Warrant One [Member]
Warrant Two [Member]
I P Purchase Agreement [Member]
Series C Preferred Stock [Member]
Investment, Name [Axis]
Mango Rx Mexico [Member]
Mango Rx U K Limited [Member]
Antidilutive Securities [Axis]
Options [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Mango Rx I P Holdings L L C [Member]
Derivative [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Long-Lived Tangible Asset [Axis]
Computer Equipment [Member]
Equipment [Member]
Stock Purchase Agreement [Member]
Cohen Enterprises Inc [Member]
Cohen Enterprises [Member]
Zip Doctor Inc [Member]
Ronin Equity Partners [Member]
Dojo Labs [Member]
Restricted Stock [Member]
Bethor Ltd [Member]
Dr.Rudman [Member]
Mr.Boon [Member]
Consulting Agreements [Member]
Private Placement Warrant One [Member]
Private Placement Warrant Two [Member]
Private Placement Warrant Three [Member]
Private Placement Warrant Four [Member]
Private Placement Warrant Five [Member]
Private Placement Warrant Six [Member]
Private Placement Warrant Seven [Member]
Mrs.Hammer [Member]
Private Placement Warrant [Member]
Mr Andrew [Member]
Plan Name [Axis]
2022 Plan [Member]
Major Dodge [Member]
Street Group LLC [Member]
Greentree Financial Group [Member]
Service Agreement [Member]
Consulting Agreement [Member]
Luca Consulting, LLC [Member]
Jason Szkup [Member]
Dr Douglas Christianson [Member]
PHX Global LLC [Member]
Marius Pharmaceuticals [Member]
Chief Executive Officer [Member]
Chief Operating Officer [Member]
Statement of Income Location, Balance [Axis]
General and Administrative Expense [Member]
Investor [Member]
Six Percentage Series C Convertible Cumulative Preferred Stock [Member]
G&P General Consulting [Member]
First Level Capital [Member]
Twenty Twenty Two Equity Incentive Plan [Member]
Zvonimir Moric Consulting [Member]
Two Thousand Twenty Two Equity Incentive Plan [Member]
Acorn Management Partners L L C [Member]
Officers Directors And Employees [Member]
Chief Executive Officer And Chairman [Member]
President [Member]
Three Independent Directors [Member]
Twenty Three Accredited Investors [Member]
Exercise Price Range [Axis]
Range One [Member]
Range Two [Member]
Lease Agreement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
2022 Plan [Member]
John Dorsey [Member]
Initial Closing [Member]
Share Purchase Agreement [Member]
Second Closing [Member]
Third Closing [Member]
Fourth Closing [Member]
Purchaser [Member]
Period End Spot Rate [Member]
Geographical [Axis]
MEXICO
Average Rate [Member]
Entity Addresses [Table]
Entity Addresses [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Contact Personnel Name
Statement [Table]
Statement [Line Items]
ASSETS
CURRENT ASSETS
Cash
Inventory
Prepaid expenses - related party
TOTAL CURRENT ASSETS
NON-CURRENT ASSETS
Property and equipment, net of accumulated depreciation of $28,752 and $3,863
Property and equipment
TOTAL NON-CURRENT ASSETS
OTHER ASSETS
Deposits
Right of use - asset
Intangible assets – acquired patents
OTHER ASSETS (INCLUDING RIGHT OF USE ASSETS)
TOTAL OTHER ASSETS
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
CURRENT LIABILITIES
Accounts payable and accrued liabilities
Payroll tax liabilities
Notes payable to related parties
Right-of-use liability - operating lease
Other liabilities – patent purchase payable
TOTAL CURRENT LIABILITIES
LONG-TERM LIABILITIES
Right-of-use liability - operating lease
TOTAL LONG-TERM LIABILITIES
TOTAL LIABILITIES
COMMITMENTS AND CONTINGENCIES (SEE NOTE 11)
STOCKHOLDERS’ EQUITY
Preferred stock,value
Common stock (par value $0.0001, 200,000,000 shares authorized, of which 29,135,451 and 21,419,500 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively)
Stock warrants
Subscription receivable
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive loss
TOTAL STOCKHOLDERS’ EQUITY
Non-controlling interest
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Accumulated depreciation
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
PreferredStock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Income Statement [Abstract]
Revenues
Revenues
Cost of revenues
Cost of revenues - related party
Gross profit
Operating expenses
General and administrative expenses
Salary and benefits
Advertising and marketing
Investor relations
Stock based compensation
Total operating expenses
Loss from operations
Other expense
Other income
Imputed interest - related party
Interest expense - amortization on discount
Total other expense
Loss before income taxes
Income taxes
Net loss
Net loss attributed to non-controlling interest
Net loss attributed to Mangoceuticals, Inc.
Basic and diluted loss per share
Basic loss per share
Diluted loss per share
Weighted average number of shares outstanding
Basic
Diluted
Balance
Balance, shares
Balance
Issuance of common stock for services
Issuance of common stock for services, shares
Issuance of preferred stock B for cash
Issuance of preferred stock B for cash, shares
Amortization of discount on preferred stock
Issuance of preferred stock C for patent acquisition
Issuance of preferred stock C for patent acquisition, shares
Issuance of common stock for cash
Issuance of common stock for cash, shares
Conversion of preferred stock B for common stock
Conversion of preferred stock B for common stock, shares
Issuance of common stock for conversion of preferred stock B
Issuance of common stock for conversion of preferred stock B, shares
Imputed interest related party loan repayment
Issuance of units for cash
Balance, shares
Options and warrants vested for services
Warrants exercised
Balance, shares
Translation adjustment
Warrants for services cancelled
Imputed interest
Net loss
Balance
Balance, shares
Balance
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Issuance of common stock for services
Imputed interest expense
Other income
Options vested for stock-based compensation
Loss on sale of assets
Amortization of discount on preferred stock
Warrants for service cancelled
(Increase) decrease in operating assets:
Rent Deposits
Inventory
Prepaid expenses
Operating lease right of use asset
(Decrease) increase in operating liabilities:
Accounts payable and accrued liabilities
Operating lease right of use liabilities
Payroll tax liabilities
NET CASH USED IN OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment
Sale of property and equipment
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings on notes payable to related parties
Proceeds from sales of preferred stock for cash
Proceeds from exercise of warrants
Repayment on notes payable
Repayment on notes payable - related party
Proceeds from exercise of warrants
Proceeds from sales of common stock for cash
NET CASH PROVIDED BY FINANCING ACTIVITIES
End of period
CASH AND CASH EQUIVALENTS:
Beginning of period
Effects of currency translation on cash and cash equivalents
End of period
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest
Supplemental schedule of non-cash investing and financing activities:
Issuance of Series C Convertible Preferred for patent acquisition
Series B Convertible Preferred converted to common stock
Net loss attributable to Mangoceuticals, Inc.
Other comprehensive expense
Foreign currency adjustments
Comprehensive loss
Other comprehensive expense
Net loss attributed to non-controlling interest
Comprehensive loss attributable to Mangoceuticals, Inc.
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND DESCRIPTION OF THE BUSINESS
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Prepaid Expenses-related Parties
PREPAID EXPENSES-RELATED PARTIES
Inventory Disclosure [Abstract]
INVENTORY
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT
Related Party Transactions [Abstract]
LOANS FROM RELATED PARTIES
Debt Disclosure [Abstract]
NOTES PAYABLE
Equity [Abstract]
CAPITAL STOCK
GOING CONCERN
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Income Tax Disclosure [Abstract]
INCOME TAXES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Deposits
DEPOSITS
Basis of Presentation
Cash Equivalents
Income Taxes
Net Loss Per Common Share
Use of Estimates and Assumptions
Fair Value of Financial Instruments
Property and Equipment
Concentration and Risks
Black-Scholes Option Pricing Model
Recently Issued Accounting Pronouncements
Related Parties
Stock-Based Compensation
Revenue Recognition
Inventories
Marketing and Advertising
Subsequent Events
Reclassifications
Principles of Consolidation
Non-Controlling Interest
Segment Reporting
Intangible Assets
Foreign Currency Translation and transaction
SCHEDULE OF FINANCIAL INSTRUMENTS MEASUREMENT AT FAIR VALUE
SCHEDULE OF FOREIGN CURRENCY TRANSLATION AND TRANSACTION
SCHEDULE OF PROPERTY PLANT AND EQUIPMENT
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
SCHEDULE OF STOCK OPTION ACTIVITY
SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS
SCHEDULE OF WARRANT ACTIVITY
SCHEDULE OF SHARE PURCHASE AGREEMENT
SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE
SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE
SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS
SCHEDULE OF MATURITY OF LEASE LIABILITIES
SCHEDULE OF DEFERRED TAX ASSET
SCHEDULE OF SHARE PURCHASE AGREEMENT
Number of shares issued
Purchase price
Proceeds from sale of common stock
Number of shares sold
Issuance of shares
Offering expense
Number of warrants to purchase of common stock
Exercise price per share
Number of shares issued, value
Warrants to purchase common stock
Purchase price of warrants
Aggregate amount for warrant
Share price
Sale of stock value
Consideration amount
Cash
Cumulative preferred stock description
Equity ownership percentage
Platform Operator, Crypto Asset [Table]
Platform Operator, Crypto Asset [Line Items]
Cash
Total assets
Total liabilities
Fair value, net asset (liability)
Total assets
Fair value, net asset (liability)
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Cash, FDIC insured amount
Cash equivalents
Anti-dilutive securities
Property plant and equipment estimated useful lives
Inventory write-downs
Marketing and advertising expense
Equity method investment ownership percentage.
Impairment of indefinite lived intangible assets
Prepaid expenses related party
Security deposits
Equipment
Less accumulated depreciation:
Property and equipment, net
Computers
Equipment
Disposed equipment
Depreciation expense
Total net property plant and equipment
Acquired computers and office equipment
Depreciation
Disposed equipment
Equipment was sold
Realizing a loss on sale of assets
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Related party advances received
Issuance of shares
Equity ownership interest
Proceeds from issuance of common stock
Repayment of related party debt
Proceeds from related party
Imputed interest percentage
Related party transaction purchases
Borrow amount
Debt instrument face amount
Debt instrument periodic payment
Repayments of notes payable
Notes payable
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options, Outstanding Beginning Balance
Weighted Average Exercise Price, Outstanding Beginning Balance
Options, Granted
Weighted Average Exercise Price, Granted
Options, Exercised
Weighted Average Exercise Price, Exercised
Options, Expired
Weighted Average Exercise Price, Expired
Options, Outstanding Ending Balance
Weighted Average Exercise Price, Outstanding Ending Balance
Options, Exercisable Ending Balance
Weighted Average Exercise Price, Exercisable Ending Balance
Options Term
Options, Expired
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair Value of Common Stock on measurement date
Risk-free interest rate
Volatility
Dividend rate
Expected term
Warrants Beginning Balance
Weighted Average Exercise Price Beginning Balance
Warrants Granted
Weighted Average Exercise Price Granted
Warrants Exercised
Weighted Average Exercise Price Exercised
Warrants Expired
Weighted Average Exercise Price Expired
Warrants Cancelled
Weighted Average Exercise Price Cancelled
Warrants Outstanding, Ending balance
Weighted Average Exercise Price Ending Balance
Warrants Exercisable Ending balance
Weighted Average Exercise Price Exercisable price
Weighted Average Exercise Price Exercisable price
Outstanding and Vested Warrants Ending balance
Outstanding and Vested Warrants Expected Term
Warrants Beginning Balance
Weighted Average Exercise Price Beginning Balance
Warrants Granted
Weighted Average Exercise Price Granted
Warrants Exercised
Weighted Average Exercise Price Exercised
Warrants Expired
Weighted Average Exercise Price Expired
Warrants Cancelled
Weighted Average Exercise Price Cancelled
Warrants Outstanding, Ending balance
Weighted Average Exercise Price Ending Balance
Warrants Exercisable Ending balance
Preferred stock, par value
Number of shares issued value
Shares price per share
Compensation expense
Gross proceeds
Sale of stock price
Consideration paid
Annual salary
Exercise price
Shares vesting
Shares issued in consideration
Shares issued value
Settlement description
Number of options
Number of options granted
Exercise price
Vesting term
Share based compensation
Fair value of options outstanding
Fair value of warrants
Fair value of warrants outstanding
Exercise of warrants shares
Outstanding and vested warrants expected term
Preferred stock stated value
Number of converted shares
Conversion price
Stock options description
Number of restricted shares issued
Number of additional restricted common shares issued
Number of restricted stock value
Agreement payable in cash
Consulting agreement description
Number of converted shares
Number of options unvested
Share based compensation
Exercisable options outstanding
Number of shares issued upon exercise
Warrants outstanding
Outstanding and vested warrants expected term
Net loss
Accumulated deficit
Net loss
2025
2025
Later years
Total lease payments
Less: Imputed interest
Present value of lease liabilities
2024
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Area of Land
Lease term
Base rent
Percentage of proportionate rent
Percentage of incremental borrowing rate
Operating lease, right-of-use asset
Operating lease, liability
Operating lease, cost
Asset impairment charges
Operating lease, description
Deferred Tax Asset
Valuation Allowance
Net Deferred Tax Asset
Change in Unrecognized Tax Benefit, Reasonably Possible [Table]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Statutory federal income tax rate, percentage
Deferred tax asset net operating loss
Decrease in deferred tax assets, valuation allowance
US federal income corporate tax rates
Net operating loss carry forwards
Subsequent Event [Table]
Subsequent Event [Line Items]
Number of restricted common shares issued
Share price
Number of restricted common shares issued, value
Number of stock available for awards description
Number of stock issued
Number of stock issued granted
Number of stock issued exercise
Conversion of stock shares converted
Initial Stated Value of Preferred Stock to be issued by installment
Warrants to be issued
Closing Date
Aggregate Purchase Price by installment
Period end spot rate
Weighted Average Outstanding
Outstanding Options
Weighted Average Exercise Price, Exercisable
Exercisable Options
Fair value of common stock on measurement date
Risk free interest rate
Dividend yield
Schedule Of Warrants Outstanding And Exercisable
Weighted Average Exercise Price Exercised
Outstanding and Vested Warrants Ending balance
Deposit
Balance amount
Prepaid expenses related party.
Fixed assets.
Imputed interest related party.
Stock issued during the period value issuance of units for cash.
Adjustments to additional paid in capital stock imputed interest.
Stock issued during the period value warrant exercised.
Stock issued during the period shares warrant exercised.
Issuance of common stock for services.
Imputed interest expense.
Warrants for service cancelled.
Increase decrease in rent deposit.
Increase decrease in operating lease right of use asset.
Increase decrease in payroll tax liabilities.
Accounts payable for purchase of property and equipment.
Resale Prospectus [Member]
Options [Member]
Related Parties Policy [Text Block].
Prepaid Expenses [Text Block]
Dojo Labs [Member]
Bethor Ltd [Member]
Rudman [Member]
Boon [Member]
Consulting Agreements [Member]
Private Placement Warrant One [Member]
Private Placement Warrant Two [Member]
Private Placement Warrant Three [Member]
Private Placement Warrant Four [Member]
Private Placement Warrant Five [Member]
Private Placement Warrant Six [Member]
Private Placement Warrant Seven [Member]
Hammer [Member]
Private Placement Warrant [Member]
Mr Andrew [Member]
2022 Plan [Member]
Major Dodge [Member]
Street Group LLC [Member]
Greentree Financial Group [Member]
Service Agreement [Member]
Consulting Agreement [Member]
Luca Consulting, LLC [Member]
Stock Purchase Agreement [Member]
Cohen Enterprises Inc [Member]
Cohen Enterprises [Member]
Interest Expense Related Party Percentage.
Zip Doctor Inc [Member]
Jason Szkup [Member]
Total assets fair value disclosure.
Dr Douglas Christianson [Member]
PHX Global LLC [Member]
Marius Pharmaceuticals [Member]
Range One [Member]
Range Two [Member]
Share based compensation arrangement by share based payment award equity instruments other than options exercised in period.
Share based compensation arrangement by share based payment award equity instruments other than options expired in period.
Share based compensation arrangement by share based payment award other than options exercisable number.
Share based payment award equity instruments other than options exercised in period weighted average grant date fair value.
Share based payment award equity instruments other than options expired in period weighted average grant date fair value.
Share based payment award other than options exercisable weighted average exercise price.
The number of vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date
Share based compensation arrangement by share based payment award fair value assumptions expected term.
Percentage of proportionate rent.
Lease Agreement [Member]
Percentage of incremental borrowing rate.
Lessee operating lease liability payments due after year two.
Luca [Member]
Sharebased compensation arrangement by sharebased payment award fair value assumption expected term.
Management Estimated And Assumptions [Policy Text Block]
G &P General Consulting [Member]
Agreement payable in cash.
Consulting agreement description.
First Level Capital [Member]
Additional stock issued during period shares restricted stock award gross.
Decrease in deferred tax assets valuation allowance.
Underwriters [Member]
Underwriting Agreement [Member]
Investor relations.
Prepaid Expenses Related Parties [Text Block]
Zvonimir Moric Consulting [Member]
Adjustments to additional paid in capital stock imputed interest related party loan repayment.
2022 Plan [Member]
2022 Plan [Member] [Default Label]
Assets, Current
AssetsNoncurrentExcludingOtherAssets
OtherAssetsIncludingRightOfUseAssets
Assets
Liabilities, Current
Operating Lease, Liability, Noncurrent
Liabilities, Noncurrent
Liabilities
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable
Equity, Attributable to Parent
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
Revenues [Default Label]
Gross Profit
Operating Expenses
Operating Income (Loss)
Other Nonoperating Income
ImputedInterestRelatedParty
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Net Income (Loss) Attributable to Parent
Shares, Outstanding
StockIssuedDuringThePeriodSharesWarrantExercised
Adjustments to Additional Paid in Capital, Warrant Issued
Issuance of Stock and Warrants for Services or Claims
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
AmortizationOfDiscountOnPreferredStock
Increase (Decrease) in Deposit Assets
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Increase (Decrease) in Income Taxes Payable
Net Cash Provided by (Used in) Operating Activities
Net Cash Provided by (Used in) Investing Activities
Proceeds from Issuance of Warrants
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
ScheduleOfSharePurchaseAgreementTableTextBlock
Cash [Default Label]
Cash and Cash Equivalents, Fair Value Disclosure
Machinery and Equipment, Gross
DisposedEquipmentPropertyPlantAndEquipment
Depreciation, Depletion and Amortization
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherOptionsExercisableWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
Debt Conversion, Converted Instrument, Shares Issued
Lessee, Operating Lease, Liability, to be Paid, Year Two
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance